CovidVax show full list
COVID-19 VACCINE:

MVA encoded VLP

researcher:
GeoVax + BravoVax
https://geovax.com/technology-pipeline/i...
http://www.bravovax.com/
(USA + China)
vaccine type: Non-replicating viral vector
Distribution updates
currently no distribution info
Human Testing updates (clinical trials)

PHASE 1

 

in definition (expecting to start Q4 2020)

Apr 01GeoVax is looking for funding to start human testing by the end of 2020 (by wgxa.tv)
Animal Testing updates (pre-clinical trials)
start date: March 2020
developed 3 vaccine candidates
Mar 09GeoVax will be ready for animal testing within two to three weeks (by wgxa.tv)
early development updates
Jan 28GeoVax announced that NIAID has awarded the company a Small Business Innovative Research grant in suppotrt of its vaccine development (by geovax.com)
Mar 18GeoVax Labs developed 3 vaccine candidates which will soon go into animal studies (by geovax.com)
Mar 04GeoVax is working on a vaccine development process to speed-up testing and validation (by geovax.com)



partnerships:
Jan 11GeoVax announced the signing of a Patent and Biological Materials License Agreement with NIAID in support of Geovax's non-clinical development of vaccines (by geovax.com)
Oct 26GeoVax announced the signing of a Patent and Biological Materials License Agreement with NIAID in support of Geovax's vaccine development (by geovax.com)
Jan 27GeoVax and BravoVax start partnership to developing a new vaccine (by geovax.com)



contact | about | ©2020 CovidVax.org project